Page last updated: 2024-08-23

cabergoline and quinagolide

cabergoline has been researched along with quinagolide in 42 studies

Research

Studies (42)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	11 (26.19)	18.2507
2000's	17 (40.48)	29.6817
2010's	11 (26.19)	24.3611
2020's	3 (7.14)	2.80

Authors

Authors	Studies
Carraro, A; Cuttica, M; Giordano, G; Giusti, M; Porcella, E; Valenti, S	1
Webster, J	3
Cerbone, G; Cirillo, S; Colao, A; Di Sarno, A; Ferone, D; Lombardi, G; Marzullo, P; Merola, B; Sarnacchiaro, F	1
Delgrange, E; Donckier, J	1
Colao, A; Lombardi, G	1
Colao, A; Di Sarno, A; Di Somma, C; Facciolli, G; Klain, M; Landi, ML; Lombardi, G; Panza, N; Pivonello, R; Salvatore, M	1
Conner, P; Fried, G	1
Crabbé, J; Delgrange, E; Donckier, J	1
Colao, A; Di Sarno, A; Di Somma, C; Klain, M; Loche, S; Lombardi, G; Pietrosante, M; Pivonello, R; Salvatore, M	1
Cerbone, G; Colao, A; Di Sarno, A; Di Somma, C; Ferone, D; Lastoria, S; Lombardi, G; Lucci, R	1
Cerbone, G; Colao, A; Di Sarno, A; Di Somma, C; Landi, ML; Lombardi, G; Marzullo, P; Pivonello, R	1
Colao, A; Di Somma, C; Ferone, D; Filippella, M; Lombardi, G; Marzullo, P; Pivonello, R	1
Cappabianca, P; Colao, A; Del Basso de Caro, ML; Faggiano, A; Ferone, D; Lastoria, S; Lombardi, G; Pivonello, R	1
Colao, A; di Sarno, A; di Somma, C; Lombardi, G; Pivonello, R	1
Góth, M; Hubina, E; Kovács, L; Szabolcs, I	1
Bankowski, BJ; Zacur, HA	1
Trifonov, I	1
Goadsby, PJ; Levy, MJ; Matharu, MS; Meeran, K; Powell, M	1
Crosignani, PG	1
Bronstein, MD	1
Barlier, A; Jaquet, P	1
de Herder, WW; Feelders, RA; Krenning, EP; Kwekkeboom, DJ; Reijs, AE; Tanghe, HL; van Aken, MO; van der Lely, AJ	1
Chuang, E; Molitch, ME	1
Atkin, SL; Lowry, M; Manuchehri, AM; Rowland-Hill, C; Sathyapalan, T; Turnbull, LW	1
Jin, ZM	1
Molitch, ME	1
Adamidou, F; Anagnostis, P; Efstathiadou, Z; Karathanassi, E; Kita, M; Polyzos, SA	1
Bath, L; Cackett, P; Eunson, G; Mulvihill, A	1
Góth, M	1
Jensen, TS; Jørgensen, JO; Kallestrup, MM; Kasch, H; Nielsen, E; Østerby, T	1
Beketić-Orešković, L; Ježek, D; Kasum, M; Orešković, S; Pekez, M; Stanić, P; Vrčić, H	1
Chapman, IM; De Sousa, SM; Falhammar, H; Torpy, DJ	1
Hart, RJ; Mourad, S; Tang, H; Zhai, SD	1
Beckers, A; Bonneville, JF; Brue, T; Castinetti, F; Cuny, T; Dufour, H; Eroukhmanoff, J; Potorac, I; Tejedor, I; Touraine, P; Weryha, G	1
Čehić, E; Franulić, D; Grgić, F; Kasum, M; Lila, A; Orešković, S; Vujić, G	1
Boutinaud, M; Lacasse, P; Vanacker, N; Zhao, X	1
Hart, RJ; Mourad, SM; Tang, H; Wang, A; Zhai, SD	1
Auriemma, RS; Colao, A; Negri, M; Patalano, R; Pirchio, R; Pivonello, C; Pivonello, R	1
Huang, Q; Li, M; Tan, J; Zeng, Y; Zhou, W; Zou, Y	1

Reviews

18 review(s) available for cabergoline and quinagolide

Article	Year
New drugs for hyperprolactinaemia. Drug and therapeutics bulletin, 1995, Volume: 33, Issue:9 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Clinical Trials as Topic; Ergolines; Hormone Antagonists; Humans; Hyperprolactinemia	1995
A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation. Drug safety, 1996, Volume: 14, Issue:4 Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Lactation; Male; Pregnancy	1996
Hyperprolactinemia; etiology, diagnosis and treatment alternatives. Acta obstetricia et gynecologica Scandinavica, 1998, Volume: 77, Issue:3 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Pergolide; Prolactin; Receptors, Prolactin	1998
Dopamine receptor agonists for treating prolactinomas. Expert opinion on investigational drugs, 2002, Volume: 11, Issue:6 Topics: Aminoquinolines; Animals; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Ergot Alkaloids; Female; Humans; Pergolide; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	2002
[Novel pharmacologic therapies in acromegaly]. Orvosi hetilap, 2002, May-12, Volume: 143, Issue:19 Suppl Topics: Acromegaly; Adenoma; Aminoquinolines; Antineoplastic Agents, Hormonal; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Hormones; Human Growth Hormone; Humans; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Prolactin; Receptors, Somatotropin; Somatostatin	2002
Dopamine agonist therapy for hyperprolactinemia. Clinical obstetrics and gynecology, 2003, Volume: 46, Issue:2 Topics: Aminoquinolines; Benzothiazoles; Bromocriptine; Cabergoline; Clinical Trials as Topic; Dopamine Agonists; Ergolines; Ergoloid Mesylates; Female; Humans; Hyperprolactinemia; Indoles; Pergolide; Pramipexole; Thiazoles	2003
[Prolactinoma and pregnancy]. Akusherstvo i ginekologiia, 2004, Volume: 43 Suppl 2 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	2004
Current treatment issues in female hyperprolactinaemia. European journal of obstetrics, gynecology, and reproductive biology, 2006, Apr-01, Volume: 125, Issue:2 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pituitary Neoplasms; Pregnancy; Prolactinoma	2006
Prolactinomas and pregnancy. Pituitary, 2005, Volume: 8, Issue:1 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Child; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Prolactinoma	2005
Quinagolide--a valuable treatment option for hyperprolactinaemia. European journal of endocrinology, 2006, Volume: 154, Issue:2 Topics: Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Male; Patient Compliance	2006
[Drug therapy for acromegaly]. Orvosi hetilap, 2013, Sep-29, Volume: 154, Issue:39 Topics: Acromegaly; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Drug Therapy, Combination; Ergolines; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Interdisciplinary Communication; Membrane Proteins; Octreotide; Patient Care Team; Peptides, Cyclic; Pituitary Neoplasms; Somatostatin	2013
Dopamine agonists in prevention of ovarian hyperstimulation syndrome. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2014, Volume: 30, Issue:12 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Ovulation Induction	2014
Dopamine agonists for preventing ovarian hyperstimulation syndrome. The Cochrane database of systematic reviews, 2016, 11-30, Volume: 11 Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Reproductive Techniques, Assisted	2016
Current Medical Strategies in the Prevention of Ovarian Hyperstimulation Syndrome Acta clinica Croatica, 2017, Volume: 56, Issue:1 Topics: Aminoquinolines; Bromocriptine; Buserelin; Cabergoline; Chorionic Gonadotropin; Dopamine Agonists; Ergolines; Estradiol; Estrogens; Female; Fertility Agents, Female; Fertilization in Vitro; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Oocyte Retrieval; Ovarian Hyperstimulation Syndrome; Ovulation Induction; Pregnancy; Pregnancy Rate; Progesterone; Progestins; Triptorelin Pamoate	2017
Review: Inhibition of prolactin as a management tool in dairy husbandry. Animal : an international journal of animal bioscience, 2019, Volume: 13, Issue:S1 Topics: 3-Hydroxybutyric Acid; Aminoquinolines; Animal Husbandry; Animals; Cabergoline; Cattle; Energy Metabolism; Fatty Acids, Nonesterified; Female; Lactation; Mammary Glands, Animal; Milk; Prolactin	2019
Dopamine agonists for preventing ovarian hyperstimulation syndrome. The Cochrane database of systematic reviews, 2021, 04-14, Volume: 4 Topics: Abortion, Spontaneous; Administration, Oral; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Fertilization in Vitro; Humans; Live Birth; Ovarian Hyperstimulation Syndrome; Placebos; Pregnancy; Pregnancy Rate; Randomized Controlled Trials as Topic; Sperm Injections, Intracytoplasmic	2021
Resistance to Dopamine Agonists in Pituitary Tumors: Molecular Mechanisms. Frontiers in endocrinology, 2021, Volume: 12 Topics: ACTH-Secreting Pituitary Adenoma; Adenoma; Aminoquinolines; beta-Arrestins; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Filamins; Growth Hormone-Secreting Pituitary Adenoma; Humans; Lisuride; MicroRNAs; Pergolide; Pituitary Neoplasms; Prolactinoma; Receptors, Dopamine D2	2021
The efficacy and safety of quinagolide in hyperprolactinemia treatment: A systematic review and meta-analysis. Frontiers in endocrinology, 2023, Volume: 14 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Drug-Related Side Effects and Adverse Reactions; Humans; Hyperprolactinemia; Pituitary Neoplasms	2023

Trials

4 trial(s) available for cabergoline and quinagolide

Article	Year
A cross-over study with the two novel dopaminergic drugs cabergoline and quinagolide in hyperprolactinemic patients. Journal of endocrinological investigation, 1994, Volume: 17, Issue:1 Topics: Administration, Oral; Adult; Aminoquinolines; Cabergoline; Dopamine Agents; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Hyperprolactinemia; Middle Aged; Prolactin	1994
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males. The Journal of clinical endocrinology and metabolism, 1998, Volume: 83, Issue:3 Topics: Adult; Aminoquinolines; Biomarkers; Bone and Bones; Bone Density; Bone Diseases, Metabolic; Bone Remodeling; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hyperprolactinemia; Male; Middle Aged; Prospective Studies	1998
Hormone levels and tumour size response to quinagolide and cabergoline in patients with prolactin-secreting and clinically non-functioning pituitary adenomas: predictive value of pituitary scintigraphy with 123I-methoxybenzamide. Clinical endocrinology, 2000, Volume: 52, Issue:4 Topics: Adenoma; Adult; Aminoquinolines; Benzamides; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Patient Selection; Pituitary Neoplasms; Predictive Value of Tests; Prolactin; Prolactinoma; Radionuclide Imaging	2000
The effect of quinagolide and cabergoline, two selective dopamine receptor type 2 agonists, in the treatment of prolactinomas. Clinical endocrinology, 2000, Volume: 53, Issue:1 Topics: Adult; Aminoquinolines; Cabergoline; Cross-Over Studies; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine D2; Treatment Outcome	2000

Other Studies

20 other study(ies) available for cabergoline and quinagolide

Article	Year
Effect of different dopaminergic agents in the treatment of acromegaly. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:2 Topics: Acromegaly; Adult; Aminoquinolines; Bromocriptine; Cabergoline; Delayed-Action Preparations; Dopamine Agonists; Ergolines; Female; Human Growth Hormone; Humans; Male; Middle Aged; Prolactin	1997
Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:8 Topics: Aminoquinolines; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Pituitary Neoplasms; Prolactinoma	1997
Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy. The Journal of clinical endocrinology and metabolism, 1997, Volume: 82, Issue:8 Topics: Aminoquinolines; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Pituitary Neoplasms; Prolactinoma	1997
Late development of resistance to bromocriptine in a patient with macroprolactinoma. Hormone research, 1998, Volume: 49, Issue:5 Topics: Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Drug Resistance, Neoplasm; Ergolines; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma	1998
Dopamine agonist therapy in hyperprolactinemia. The Journal of reproductive medicine, 1999, Volume: 44, Issue:12 Suppl Topics: Aminoquinolines; Cabergoline; Dopamine Agonists; Drug Administration Schedule; Ergolines; Female; Humans; Hyperprolactinemia; Male; Pregnancy; Pregnancy Complications	1999
Prolactinomas in adolescents: persistent bone loss after 2 years of prolactin normalization. Clinical endocrinology, 2000, Volume: 52, Issue:3 Topics: Adolescent; Adult; Aminoquinolines; Analysis of Variance; Biomarkers; Bone Density; Bone Remodeling; Bromocriptine; Cabergoline; Case-Control Studies; Collagen; Collagen Type I; Dopamine Agonists; Ergolines; Female; Femur Neck; Humans; Longitudinal Studies; Lumbar Vertebrae; Male; Middle Aged; Osteocalcin; Osteoporosis; Peptides; Pituitary Neoplasms; Prolactinoma; Regression Analysis	2000
Efficacy of combined treatment with lanreotide and cabergoline in selected therapy-resistant acromegalic patients. Pituitary, 1999, Volume: 1, Issue:2 Topics: Acromegaly; Adult; Aminoquinolines; Cabergoline; Dopamine Agonists; Drug Synergism; Drug Therapy, Combination; Ergolines; Female; Hormones; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Octreotide; Peptides, Cyclic; Somatostatin; Time Factors	1999
Cabergoline and quinagolide therapy for prolactinomas. Clinical endocrinology, 2000, Volume: 53, Issue:5 Topics: Aminoquinolines; Cabergoline; Cross-Over Studies; Dopamine Agonists; Ergolines; Female; Humans; Magnetic Resonance Imaging; Pituitary Neoplasms; Prolactinoma; Research Design; Treatment Outcome	2000
In vivo and in vitro effects of octreotide, quinagolide and cabergoline in four hyperprolactinaemic acromegalics: correlation with somatostatin and dopamine D2 receptor scintigraphy. Clinical endocrinology, 2001, Volume: 54, Issue:4 Topics: Acromegaly; Adrenocorticotropic Hormone; Adult; Aminoquinolines; Analysis of Variance; Antineoplastic Agents, Hormonal; Cabergoline; Dopamine Agonists; Ergolines; Female; Follicle Stimulating Hormone; Growth Hormone; Humans; Immunohistochemistry; Indium Radioisotopes; Insulin-Like Growth Factor I; Iodine Radioisotopes; Luteinizing Hormone; Male; Octreotide; Pituitary Neoplasms; Prolactin; Prolactinoma; Receptors, Dopamine; Receptors, Somatostatin; Thyrotropin; Tumor Cells, Cultured	2001
The clinical characteristics of headache in patients with pituitary tumours. Brain : a journal of neurology, 2005, Volume: 128, Issue:Pt 8 Topics: Adenoma; Adult; Aminoquinolines; Antineoplastic Agents, Hormonal; Bromocriptine; Cabergoline; Disability Evaluation; Dopamine Agonists; Ergolines; Female; Headache; Humans; Male; Migraine Disorders; Octreotide; Peptides, Cyclic; Pituitary Neoplasms; Severity of Illness Index; Somatostatin; Time Factors	2005
Dopamine agonist therapy of clinically non-functioning pituitary macroadenomas. Is there a role for 123I-epidepride dopamine D2 receptor imaging? European journal of endocrinology, 2006, Volume: 155, Issue:5 Topics: Adenoma; Adult; Aged; Aged, 80 and over; Aminoquinolines; Benzamides; Cabergoline; Dopamine Agonists; Ergolines; Female; Humans; Iodine Radioisotopes; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon	2006
Prolactin and autoimmune diseases in humans. Acta bio-medica : Atenei Parmensis, 2007, Volume: 78 Suppl 1 Topics: Aminoquinolines; Animals; Arthritis, Rheumatoid; Autoimmune Diseases; Bromocriptine; Cabergoline; Cyclosporine; Dopamine Agonists; Double-Blind Method; Drug Therapy, Combination; Ergolines; Female; Humans; Hyperprolactinemia; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Mice; Mice, Knockout; Penicillamine; Prednisone; Prolactin; Rats; Receptors, Prolactin	2007
Effect of dopamine agonists on prolactinomas and normal pituitary assessed by dynamic contrast enhanced magnetic resonance imaging (DCE-MRI). Pituitary, 2007, Volume: 10, Issue:3 Topics: Adolescent; Adult; Aged; Aminoquinolines; Cabergoline; Contraceptives, Oral, Hormonal; Dopamine Agonists; Ergolines; Female; Humans; Immunoglobulin G; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma	2007
[Some issues in the diagnosis and treatment of hyperprolactinemia]. Zhonghua fu chan ke za zhi, 2008, Volume: 43, Issue:4 Topics: Aminoquinolines; Cabergoline; Diagnosis, Differential; Dopamine Agonists; Ergolines; Female; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Pituitary Gland; Pituitary Neoplasms; Pregnancy; Prolactin; Prolactinoma	2008
Prolactinomas and pregnancy. Clinical endocrinology, 2010, Volume: 73, Issue:2 Topics: Aminoquinolines; Antineoplastic Agents; Cabergoline; Dopamine Agonists; Embryonic Development; Ergolines; Female; Humans; Pituitary Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Prolactinoma	2010
Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience. Pituitary, 2012, Volume: 15, Issue:1 Topics: Adolescent; Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; Humans; Male; Middle Aged; Prolactinoma; Treatment Outcome; Young Adult	2012
Proptosis as the presenting sign of giant prolactinoma in a prepubertal boy: successful resolution of hydrocephalus by use of medical therapy. Future oncology (London, England), 2012, Volume: 8, Issue:12 Topics: Adolescent; Aminoquinolines; Cabergoline; Dopamine Agonists; Ergolines; Exophthalmos; Humans; Hydrocephalus; Male; Pituitary Neoplasms; Prolactin; Prolactinoma	2012
Prolactinoma-associated headache and dopamine agonist treatment. Cephalalgia : an international journal of headache, 2014, Volume: 34, Issue:7 Topics: Adult; Aminoquinolines; Cabergoline; Case-Control Studies; Dopamine Agonists; Ergolines; Female; Headache; Humans; Hyperprolactinemia; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Recurrence; Substance Withdrawal Syndrome	2014
Dopa-testotoxicosis: disruptive hypersexuality in hypogonadal men with prolactinomas treated with dopamine agonists. Endocrine, 2017, Volume: 55, Issue:2 Topics: Adult; Aged; Aminoquinolines; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Humans; Hypogonadism; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Retrospective Studies; Sexual Dysfunction, Physiological	2017
MRI follow-up is unnecessary in patients with macroprolactinomas and long-term normal prolactin levels on dopamine agonist treatment. European journal of endocrinology, 2017, Volume: 176, Issue:3 Topics: Adult; Aminoquinolines; Belgium; Bromocriptine; Cabergoline; Dopamine Agonists; Ergolines; Female; Follow-Up Studies; France; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Pituitary Neoplasms; Prolactin; Prolactinoma; Retrospective Studies	2017